For now, access to GLP1s for weight management remains limited to those with qualifying diagnoses, private insurance with strong benefits, or the financial means to pay out of pocket
Active-ingredient body care: APLB was founded on the belief that body skin warrants the same active-ingredient standards as the face
The next era of weight health isnt about access to medication alone, its about helping people succeed on it, said Tara Comonte, CEO of Weight Watchers
You lose weight
As a GLP-1 receptor agonist, semaglutide acts on receptors distributed throughout the body, including the central nervous system, gastrointestinal tract, and cardiovascular system
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist